NCT03785587: A trial that was reported late by Botanix Pharmaceuticals
This trial has reported, although it was 837 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03785587 |
|---|---|
| Title | A Multi-Center Open-Label Extension Study to Assess the Long-Term Safety Tolerability and Pharmacokinetics of Sofpironium Bromide Gel 15% Applied Topically to Children and Adolescents Age 9-17 Years Previously Enrolled in BBI-4000-CL-105 |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 21, 2018 |
| Completion date | Sept. 6, 2019 |
| Required reporting date | Sept. 5, 2020, midnight |
| Actual reporting date | Dec. 22, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 837 |